Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer's Disease Under the Accelerated Approval Pathway Eisai Sep 28, 2021 10:37 HKT/SGT Read More
Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval Eisai Sep 27, 2021 13:50 HKT/SGT Read More
NEC Utilizes Digital Technologies to Create Healthcare and Life Science Business NEC Corporation Sep 15, 2021 08:59 HKT/SGT Read More
Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2021 Eisai Sep 14, 2021 11:36 HKT/SGT Read More
AbbVie, Eisai, and EA Pharma Launch "Humira Support Tool Ordering Service for Patients" Eisai Sep 13, 2021 15:37 HKT/SGT Read More
TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund TANAKA PRECIOUS METAL GROUP Co., Ltd. Sep 06, 2021 10:00 HKT/SGT Read More
富士通、説明可能なディープラーニング技術「Deep Tensor」を活用し、化学構造式のみで化合物の特性を予測する「SCIQUICK-DT」を提供開始 Fujitsu Ltd Sep 02, 2021 10:30 JST Read More
エーザイと富士薬品、痛風・高尿酸血症治療剤ドチヌラドについてASEAN 5ヵ国における開発・販売に関するライセンス契約を締結 Eisai Aug 31, 2021 08:50 JST Read More
Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad in Five ASEAN Countries Eisai Aug 31, 2021 08:42 HKT/SGT Read More
Agilex BiolabsがEndpoints Newsと提携し、オーストラリアにおける迅速なワクチン開発に関する初のウェビナーを開催 Agilex Biolabs Aug 30, 2021 12:00 JST Read More
Azelis publishes its 2020 sustainability report, demonstrating progress against ambition to innovate and advance in sustainability Azelis Aug 26, 2021 09:00 JST Read More
NECと九州大学が開発した「My-IoT開発プラットフォーム」が東京都の認知症高齢者向けIoT実証事業に採用 NEC Corporation Aug 25, 2021 10:00 JST Read More
大塚製薬工場と富士通、国立がん研究センター・国立長寿医療研究センターと患者さんの低栄養リスクのAI予測サービス構築に向けた探索的共同研究を開始 Fujitsu Ltd Aug 24, 2021 10:00 JST Read More
Anticancer Agent "Tazverik Tablets 200mg" (Tazemetostat Hydrobromide) Launched in Japan for EZH2 Gene Mutation-Positive Follicular Lymphoma Eisai Aug 16, 2021 09:07 HKT/SGT Read More
